Estrogen regulation of tumor necrosis factor-α: A missing link between menopause and cardiovascular risk in women?

Hypertension

Volumn 46, Issue 1, 2005, Pages 21-22

  Dantas, Ana Paula V ^a   Sandberg, Kathryn ^a,b,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b Center for the Study of Sex Differences in Health Aging and Disease   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN II ANTAGONIST; C REACTIVE PROTEIN; ESTROGEN; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1; INTERLEUKIN 6; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA; VASOCONSTRICTOR AGENT;

BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE COURSE; EDITORIAL; ENZYME ACTIVITY; ESTROGEN DEFICIENCY; ESTROGEN RESPONSIVE ELEMENT; ESTROGEN THERAPY; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MENOPAUSE; OVARIECTOMY; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYSTEMIC CIRCULATION; VASCULAR ENDOTHELIUM; WEIGHT GAIN;

CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; ESTROGENS; HUMANS; INFLAMMATION; MENOPAUSE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21744453151     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000169038.67923.b0     Document Type: Editorial

References (13)

1. Granger DN, Vowinkel T, Petnehazy T. Modulation of the inflammatory response in cardiovascular disease. Hypertension. 2004;43:924-931.
2. Anderson HD, Rahmutula D, Gardner DG. Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem. 2004;279:963-969.
3. Gertzberg N, Neumann P, Rizzo V, Johnson A. NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-alpha. Am J Physiol Lung Cell Mol Physiol. 2004;286:L37-L48.
4. Fruhbeck G. The adipose tissue as a source of vasoactive factors. Curr Med Chem Cardiovasc Hematol Agents. 2004;2:197-208.
5. Arenas IA, Armstrong SJ, Xu Y, Davidge ST. Chronic TNFa Inhibition Enhances Nitric Oxide Modulation of Vascular Function in Estrogen Deficient Rats. Hypertension. 2005;46:76-81.
6. Tostes RC, Nigro D, Fortes ZB, Carvalho MH. Effects of estrogen on the vascular system. Braz J Med Biol Res. 2003;36:1143-1158.
7. Sumi D, Ignarro LJ. Estrogen-related receptor alpha 1 up-regulates endothelial nitric oxide synthase expression. Proc Natl Acad Sci USA. 2003;100:14451-14456.
8. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest. 1999;103:401-406.
9. Dantas APV, Tostes RCA, Fortes ZB, Costa SG, Nigro D, Carvalho MH. In Vivo Evidence for Antioxidant Potential of Estrogen in Microvessels of Female Spontaneously Hypertensive Rats. Hypertension. 2002;39:405-411.
10. Wagner AH, Schroeter MR, Hecker M. 17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J. 2001;15:2121-2130.
11. Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocrinol Rev. 2002;23:90-119.
12. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002;288:321-333.
13. Stork S, van der Schouw YT, Grobbee DE, Bots ML. Estrogen, inflammation and cardiovascular risk in women: a critical appraisal. Trends Endocrinol Metab. 2004;15:66-72.